Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	121	66	67	104	144	92
Market Cap Growth	90.62%	-1.17%	-35.77%	-27.72%	56.56%	-12.98%
Enterprise Value	122	69	64	105	143	92
Last Close Price	8.61	4.85	4.92	7.68	10.73	7.72
PE Ratio	19.35	-	-	189.51	396.90	-
Forward PE	147.50	-	-	42.95	77.31	77.20
PS Ratio	2.00	1.32	1.24	2.12	3.50	2.86
PB Ratio	21.58	-34.65	14.39	11.42	19.34	18.00
P/TBV Ratio	29.32	-	15.51	11.85	20.26	19.26
P/FCF Ratio	-	60.64	25.25	-	133.98
P/OCF Ratio	-	16.80	15.99	-	31.59
PEG Ratio	-	-	2.86	5.44	5.15
EV/Sales Ratio	2.08	1.38	1.19	2.13	3.48	2.88
EV/EBITDA Ratio	14.46	-	-	46.90	92.05	-
EV/EBIT Ratio	18.12	-	-	172.63	389.82	-
EV/FCF Ratio	-	58.12	25.48	-	134.98
Debt / Equity Ratio	1.18	-3.90	1.86	1.04	1.29	0.75
Debt / EBITDA Ratio	0.63	-	-	2.29	3.37	19.58
Debt / FCF Ratio	-	-	7.82	2.30	-	5.55
Asset Turnover	2.04	1.66	1.55	1.56	1.70	2.01
Quick Ratio	0.96	0.56	0.83	1.06	1.04	1.07
Current Ratio	0.99	0.63	0.90	1.13	1.13	1.10
Return on Equity (ROE)	376.84%	-532.46%	-77.70%	6.63%	5.78%	-57.05%
Return on Assets (ROA)	14.64%	-14.31%	-7.98%	1.21%	0.95%	-6.19%
Return on Capital (ROIC)	47.78%	-46.11%	-17.49%	2.13%	1.76%	-17.78%
Return on Capital Employed (ROCE)	62.50%	-	-	3.40%	2.20%	-
Earnings Yield	5.42%	-11.04%	-8.00%	0.53%	0.25%	-2.28%
FCF Yield	-1.21%	-10.58%	1.65%	3.96%	-3.45%	0.75%
Buyback Yield / Dilution	-3.30%	-0.04%	4.37%	2.84%	-23.05%	15.98%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q